Aptose Biosciences (TSX:APS) Price-to-Operating-Cash-Flow : (As of May. 03, 2024)

View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences Price-to-Operating-Cash-Flow?

As of today (2024-05-03), Aptose Biosciences's share price is C$1.65. Aptose Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-9.16. Hence, Aptose Biosciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Aptose Biosciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSX:APS's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.265
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Aptose Biosciences's Cash Flow from Operations per share for the three months ended in Dec. 2023 was C$-1.58. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-9.16.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -3.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 7.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 11.20% per year.

During the past 13 years, Aptose Biosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 44.30% per year. The lowest was -33.60% per year. And the median was 15.85% per year.

Aptose Biosciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Aptose Biosciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Price-to-Operating-Cash-Flow Chart

Aptose Biosciences Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Aptose Biosciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Aptose Biosciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Aptose Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptose Biosciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptose Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aptose Biosciences's Price-to-Operating-Cash-Flow falls into.

Aptose Biosciences Price-to-Operating-Cash-Flow Calculation

Aptose Biosciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.65	/	-9.162
	=

Aptose Biosciences's Share Price of today is C$1.65.
Aptose Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-9.16.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Aptose Biosciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences (TSX:APS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

APTO:USA LTI:Germany

Address

251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences (TSX:APS) Headlines

No Headlines